Clinigen Group plc Receives FDA's First Ever Drug Shortage Assistance Award
Business Wire - Mon Sep 29, 1:28AM CDT
Clinigen Group plc ('Clinigen' or the 'Group', AIM:CLIN) the global specialty pharmaceutical company, today announces that it has received the first Drug Shortage Assistance Award from the US Food and Drug Administration (FDA) in recognition of its contribution in addressing a US shortage of Foscavir(R) (foscarnet sodium) injection.
Clinigen Group plc: Underlying EBITDA up 19.8% and EPS up 22%
Business Wire - Wed Sep 24, 1:10AM CDT
Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global specialty pharmaceuticals business, has today published its preliminary results for the 12 months ended 30 June 2014.
New Antibiotic VIBATIV(R)a- 1/4 (telavancin) Targets Public Health Priority MRSA Infections for People with Hospital-Acquired Pneumonia Across Europe
PR Newswire Europe - Thu Sep 18, 7:42AM CDT
BURTON-ON-TRENT, England, September 18, 2014 /PRNewswire/ --
Clinigen Group Further Strengthens Oncology Support Portfolio with Acquisition of Ethyol(R) (amifostine), from AstraZeneca
Business Wire - Wed Aug 20, 1:07AM CDT
Clinigen Group plc ('Clinigen' or the 'Group'
Clinigen Group Acquires Oncology Support Therapy SAVENE(R) (dexrazoxane) from SpePharm AG
Business Wire - Mon Mar 31, 1:00AM CDT
Clinigen Group plc ('Clinigen' or the 'Group'
Clinigen Group plc: Half Year Results for the Six Months Ended 31 December 2013
Business Wire - Wed Feb 26, 1:18AM CST
Clinigen Group plc (AIM: CLIN, Clinigen or the Group), the global specialty pharmaceuticals and pharmaceutical services business, has today published its half year results for the six months ended 31 December 2013.